EU drug monitoring agency voices concerns over “legal highs”BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c6491 (Published 12 November 2010) Cite this as: BMJ 2010;341:c6491
- Rory Watson
Wolfgang Götz, the director of the European Monitoring Centre for Drugs and Drug Addiction, urged governments not to cut funding of drug treatment programmes when he presented the agency’s annual report in Lisbon on 10 November.
As public expenditure is being drastically cut back to reduce massive national debts, Mr Götz made a special plea for treatment schemes to reduce drug use—on which more than one million people in the European Union now depend—to be spared the budgetary axe.
“At a time when effective responses need to be sustained, austerity measures could lead to reductions in treatment services,” he warned. “Current pressures …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial